CSIMarket
 


Eli Lilly And Company  (LLY)
Other Ticker:  
 


Eli Lilly's Net Profit Margin by quarter

Trends, Rankings, Statistics



LLY Net Profit Margin (Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
Y / Y Revenue Change -3.74 % 14.76 % 7.53 % 17.98 % 22.56 %
Seq. Revenue Change -16.93 % -2.37 % 18.12 % 0.49 % -0.96 %
Revenue In Millions $6,488.00 $7,810.00 $7,999.90 $6,772.80 $6,740.10
Net Profit Margin 14.68 % 24.36 % 21.58 % 16.39 % 20.63 %
Net Profit Margin Total Ranking # 1166 # 773 # 1055 # 1225 # 1010
Net Income In Millions $952.50 $1,902.90 $1,726.10 $1,110.10 $1,390.20
Y / Y Net Income Change -31.48 % 40.4 % -18.46 % -8.13 % -1.54 %
Seq. Net Income Change -49.94 % 10.24 % 55.49 % -20.15 % 2.58 %


Commenting Second Quarter 2022 Net Profit Margin
Eli Lilly And Company experienced contraction in Net Income by -49.94 % to $6,488 millions and Revenue by -16.93 %, while Net Profit Margin fell to 14.68 %, below company's average Net Profit Margin.

Observing second quarter 2022 results within Major Pharmaceutical Preparations industry 29 other companies have achieved higher Net Profit Margin. While Net Profit Margin overall ranking has deteriorated compare to previous quarter from 773 to 1166.
Net Margin Formula
LLY's Net Profit Margin second quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 30
Healthcare Sector # 70
Overall # 1166

Net Profit Margin Statistics
High Average Low
83.3 % 19.06 % 3.12 %
(Mar 31 2019)   (Dec. 31, 2006)




Other Net Profit Margin Profitability Ratios
LLY's Cumulative Net Profit Margin
Major Pharmaceutical Preparations Industry Net Profit Margin Trends and Statistics
Healthcare Sector Net Profit Margin Statistics
Net Profit Margin Profitability Trends for overall market
LLY's Net Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Profit Margin
Lowest Ranking Net Profit Margin
Net Profit Margin Profit Margin for LLY's Competitors
Net Profit Margin Profit Margin for Eli Lilly's Suppliers
Net Profit Margin Profit Margin for LLY's Customers

You may also want to know
LLY's Annual Growth Rates LLY's Profitability Ratios LLY's Asset Turnover Ratio LLY's Dividend Growth
LLY's Roe LLY's Valuation Ratios LLY's Financial Strength Ratios LLY's Net Income Growth
LLY's Roa LLY's Inventory Turnover Ratio LLY's Growth Rates LLY's Dividend Comparisons


Companies with similar Net Profit Margin in the quarter ending Jun 30 2022, within Major Pharmaceutical Preparations Industry Net Profit MarginJun 30 2022 MRQ Net IncomeJun 30 2022 MRQ Revenue
Ironwood Pharmaceuticals inc.  38.14 %$ 37.080 $ 97.231 
Vertex Pharmaceuticals Inc  36.90 %$ 810.500 $ 2,196.200 
Pfizer Inc  35.73 %$ 9,911.000 $ 27,742.000 
Regeneron Pharmaceuticals Inc.  29.82 %$ 852.100 $ 2,857.200 
Merck and Co. Inc.  27.06 %$ 3,949.000 $ 14,593.000 
Corcept Therapeutics Inc  26.50 %$ 27.398 $ 103.386 
Zoetis Inc.  25.78 %$ 529.000 $ 2,052.000 
Prophase Labs Inc.  25.59 %$ 7.446 $ 29.092 
United Therapeutics Corporation  24.84 %$ 116.000 $ 466.900 
Akebia Therapeutics Inc.  23.10 %$ 29.276 $ 126.759 
Assertio Holdings inc.  22.30 %$ 7.834 $ 35.131 
Harmony Biosciences Holdings inc.  21.99 %$ 23.531 $ 107.028 
Johnson and Johnson  20.04 %$ 4,814.000 $ 24,020.000 
Innoviva Inc.  19.75 %$ 21.371 $ 108.220 
Lftd Partners Inc.  19.19 %$ 3.219 $ 16.777 
Abbott Laboratories  17.93 %$ 2,018.000 $ 11,257.000 
Puma Biotechnology Inc.  15.74 %$ 9.371 $ 59.518 
Organon and Co.  14.76 %$ 234.000 $ 1,585.000 
Eli Lilly And Company  14.68 %$ 952.500 $ 6,488.000 
Amphastar Pharmaceuticals Inc.  14.05 %$ 17.346 $ 123.467 
Siga Technologies Inc  12.22 %$ 2.037 $ 16.667 
Bristol myers Squibb Company  12.02 %$ 1,429.000 $ 11,887.000 
Pacira Biosciences inc.  11.73 %$ 19.876 $ 169.411 
Viatris Inc.  7.62 %$ 313.900 $ 4,116.800 
Organogenesis Holdings Inc.  7.20 %$ 8.744 $ 121.401 
Horizon Therapeutics Public Limited Company  6.96 %$ 60.974 $ 876.411 
Biomarin Pharmaceutical Inc  5.18 %$ 27.664 $ 533.798 
Supernus Pharmaceuticals inc.  4.63 %$ 7.865 $ 170.051 
Avid Bioservices Inc.  4.26 %$ 1.564 $ 36.692 
Dar Bioscience Inc.  4.14 %$ 0.414 $ 10.000 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

HJGP's Profile

Stock Price

HJGP's Financials

Business Description

Fundamentals

Charts & Quotes

HJGP's News

Suppliers

HJGP's Competitors

Customers & Markets

Economic Indicators

HJGP's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071